Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 550 of 984 entries
View as:

A Study to Evaluate the Effect of the Potent Cytochrome P-450 3A4 (CYP3A4) Inhibitor Itraconazole on the Pharmacokinetics (PK) of TAK-954 in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT03173170 Org: User:
Start: 05/31/17 End: 07/24/17 Due: 07/24/18

An Extension Study of TAK-664 for Japanese People With Primary Immunodeficiency Disease

Phase: N/A Priority: Normal
NCT ID: NCT04842643 Org: User:
Start: 04/27/21 End: 04/25/24 Due: 04/25/25

A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)

Phase: N/A Priority: Normal
NCT ID: NCT05582993 Org: User:
Start: 11/06/24 End: 04/11/30 Due: 04/11/31

A Study on How Vedolizumab is Given and the Outcomes for Adults With Inflammatory Bowel Disease (VARIETY-Belgium)

Phase: N/A Priority: Normal
NCT ID: NCT04959851 Org: User:
Start: 12/02/21 End: 06/18/24 Due: 06/18/25

A Study to Characterize Multidimensional Model to Predict the Course of Crohn's Disease (CD)

Phase: N/A Priority: Normal
NCT ID: NCT03668249 Org: User:
Start: 09/26/18 End: 09/16/19 Due: 09/16/20

A Study of Enzyme Replacement Therapy (VPRIV) in People With Type 1 Gaucher Disease Who Were Previously Treated With Substrate Reduction Therapy

Phase: N/A Priority: Normal
NCT ID: NCT04718779 Org: User:
Start: 04/22/21 End: 02/16/23 Due: 02/16/24

Voglibose Tablets 0.2 / OD Tablets 0.2 Special Drug Use Surveillance "Long-term Use in Patients With Impaired Glucose Tolerance"

Phase: N/A Priority: Normal
NCT ID: NCT01993927 Org: User:
Start: 11/18/09 End: 08/31/13 Due: 08/31/14

Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout

Phase: N/A Priority: Normal
NCT ID: NCT02139046 Org: User:
Start: 04/30/14 End: 11/30/15 Due: 11/30/16

36-month Special Drug Use Surveillance on Frequency of Bone Fractures With Sodium Risedronate 75 mg Tablets

Phase: N/A Priority: Normal
NCT ID: NCT02106442 Org: User:
Start: 05/13/13 End: 04/30/18 Due: 04/30/19

Safety, Tolerability and Pharmacokinetic Study of Multiple Rising Doses of TAK- 063 in Participants With Stable Schizophrenia and Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT01879722 Org: User:
Start: 06/30/13 End: 06/30/14 Due: 06/30/15

Efficacy and Safety of Dexlansoprazole MR on Maintaining Healing in Subjects With Healed Erosive Esophagitis

Phase: N/A Priority: Normal
NCT ID: NCT00255164 Org: User:
Start: 01/31/06 End: 11/30/06 Due: 11/30/07

Azilsartan Medoxomil (TAK-491) Compared to Valsartan in Chinese Participants With Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT02480764 Org: User:
Start: 08/27/15 End: 10/13/17 Due: 10/13/18

A Study to Investigate the Relationship Between Duration of Treatment and Response in Patients With Multiple Myeloma (MM) or Systemic AL Amyloidosis Treated in Real-life Practice

Phase: N/A Priority: Normal
NCT ID: NCT04659798 Org: User:
Start: 01/22/21 End: 09/05/23 Due: 09/05/24

Study of the QOL Evaluation of Trelagliptin in Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT03014479 Org: User:
Start: 02/18/17 End: 10/21/17 Due: 10/21/18

Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-137 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT02334982 Org: User:
Start: 06/30/13 End: 01/31/14 Due: 01/31/15

Efficacy of Lapaquistat Acetate in Subjects Currently Treated With Lipid-Lowering Therapy.

Phase: N/A Priority: Normal
NCT ID: NCT00251680 Org: User:
Start: 10/31/05 End: 05/31/07 Due: 05/31/08

A First-In-Human Study of TAK-004 in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT06236009 Org: User:
Start: 11/01/24 End: 08/07/25 Due: 08/07/26

A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04381650 Org: User:
Start: 08/17/20 End: 10/29/24 Due: 10/29/25

A Study on Cytomegalovirus (CMV) Infection Outcomes Among Solid Organ Transplant (SOT) Participants in Europe and Canada

Phase: N/A Priority: Normal
NCT ID: NCT05576805 Org: User:
Start: 06/19/23 End: 03/31/24 Due: 03/31/25

Effect of Dexlansoprazole on Bone Homeostasis

Phase: N/A Priority: Normal
NCT ID: NCT01216293 Org: User:
Start: 11/01/10 End: 02/01/15 Due: 02/01/16

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of TAK-925 Study in Sleep-Deprived Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT03522506 Org: User:
Start: 05/09/18 End: 11/07/18 Due: 11/07/19

Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Adults With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00672958 Org: User:
Start: 04/30/08 End: 11/30/08 Due: 11/30/09

A Study of Danavorexton (TAK-925) in Adults With Obstructive Sleep Apnea

Phase: N/A Priority: Normal
NCT ID: NCT05180890 Org: User:
Start: 03/10/22 End: 11/23/22 Due: 11/23/23

Safety and Efficacy of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01153009 Org: User:
Start: 06/30/10 End: 03/31/12 Due: 03/31/13

A Study of TAK-385 in Hormone Treatment-naïve Participants With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02141659 Org: User:
Start: 05/01/14 End: 04/20/17 Due: 04/20/18